Corporate highlights

Product launches Paxil?CR, DepoCyt?, Solaraze?, Xatral? OD

Good pipeline progress DepoMorphine™, Foradil?, DepoBupivacaine™

New product development Agreements with Chugai & Schering-Plough Pulmicort? (AstraZeneca), Psoraxine™ (Astralis)

Some disappointments

Corporate agreements RTP acquisition & Paul Capital

Previous slide

Next slide

Back to first slide

View graphic version